Functional Dyspepsia. Functional dyspepsia
Conditions
Interventions
Intervention 1: Intervention group: Compound honey syrup is produced by NIAK Pharmaceutical Company with the license of the Food and Drug Administration of the Ministry of Health and Medical Education
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients aged 18-60 years Patients with functional dyspepsia
Exclusion criteria
Exclusion criteria: Pregnancy Breastfeeding Active urinary tract infection History of seizure Concomitant use of a chemical or other herbal medicine associated with symptoms of functional indigestion Any possible severe drug-related side effects History of gastrointestinal ulcer or reflux disease Taking anticoagulants Irritable bowel syndrome Surgery in the esophagus and stomach and intestines Serious organ diseases such as diabetes and cardiovascular disease Consumption of any type of drug Severe mental retardation The patient's unwillingness to continue the project Failure to complete the consent form Warning symptoms (severe weight loss, anemia, blood in the stool, dysphagia)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Early satiety. Timepoint: At the beginning and end of two weeks and four weeks. Method of measurement: questionnaire.;Heaviness. Timepoint: At the beginning and end of two weeks and four weeks. Method of measurement: questionnaire.;Vomit. Timepoint: At the beginning and end of two weeks and four weeks. Method of measurement: questionnaire.;Burning epigastric area. Timepoint: At the beginning and end of two weeks and four weeks. Method of measurement: questionnaire.;Epigastric pain. Timepoint: At the beginning and end of two weeks and four weeks. Method of measurement: questionnaire.;Bloat. Timepoint: At the beginning and end of two weeks and four weeks. Method of measurement: questionnaire.;Burp. Timepoint: At the beginning and end of two weeks and four weeks. Method of measurement: questionnaire.;Nausea. Timepoint: At the beginning and end of two weeks and four weeks. Method of measurement: questionnaire.;Severity of symptoms. Timepoint: At the beginning and end of two weeks and four weeks. Method of measurement: questionnaire.;Frequency of symptoms. Timepoint: At the beginning and end of two weeks and four weeks. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRasool Choopani
Shahid Beheshti University of Medical Sciences
Outcome results
None listed